AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Contraceptives, OralBiological MarkersContraceptives, Oral, CombinedContraceptive AgentsC-Reactive ProteinContraceptives, Oral, HormonalContraceptive Agents, FemaleInflammationContraceptives, Oral, SyntheticInflammation MediatorsContraceptive DevicesContraceptionInterleukin-6Bhopal Accidental ReleaseContraceptive Devices, FemaleContraception BehaviorContraceptive Agents, MaleIntrauterine DevicesFamily Planning ServicesFibrinogenSerum Amyloid A ProteinEthinyl EstradiolDesogestrelNorgestrelLevonorgestrelContraceptives, PostcoitalRisk FactorsReceptors, Tumor Necrosis Factor, Type IIMestranolNorethindroneIntercellular Adhesion Molecule-1AtherosclerosisProspective StudiesCytokinesVaccines, Contraceptive1-Alkyl-2-acetylglycerophosphocholine EsteraseFibrin Fibrinogen Degradation ProductsPregnancy, UnplannedCardiovascular DiseasesTumor Necrosis Factor-alphaCross-Sectional StudiesCase-Control StudiesVasculitisSterilization, ReproductiveVascular Cell Adhesion Molecule-1Leukocyte CountPeroxidasePredictive Value of TestsTime FactorsPregnancy, UnwantedCohort StudiesReceptors, Tumor Necrosis Factor, Type IChemokine CCL2Anti-Inflammatory AgentsMedroxyprogesterone AcetateDouble-Blind MethodLipidsCoronary Artery DiseasePilot ProjectsRisk AssessmentSpermatocidal AgentsContraception, PostcoitalDisease ProgressionInterleukin-1betaPregnancyAnalysis of VarianceIntrauterine Devices, CopperMenstruationTreatment OutcomeNorethynodrelMultivariate AnalysisObesitySeverity of Illness IndexEthynodiol DiacetateAbortion, InducedPrognosisContraception, ImmunologicNorpregnenesEthinyl Estradiol-Norgestrel CombinationDiabetes Mellitus, Type 2ProgestinsFollow-Up StudiesBody Mass IndexLinear ModelsContraceptives, Oral, SequentialTumor Markers, BiologicalContraceptives, Postcoital, HormonalMetabolic Syndrome XCoronary DiseaseSterilization, TubalMenstrual CycleAndrostenesProgesterone CongenersParityIntrauterine Devices, MedicatedHealth Knowledge, Attitudes, PracticeContraceptive Devices, MalePregnancy in AdolescenceMenstruation DisturbancesMegestrol
Bowel diseaseEndometriosisProgesteroneIrritable bowel syTherapiesLesionsContraceptionInflammationHormonesEstrogenMenopauseSymptomsChronicBreast CancerEfficacyDiseaseFactorsGnRHTreatmentsTherapeuticYieldsIncludeAcneDiagnosticClinicalPreventionCombinationMinusSubstantiallyPainPregnancyRiskAnticoagulantsPracticeTissueMETHODSIllnessWomenStudyGroupTimeMethodMedical
Bowel disease2
  • The precise pathophysiology of HS is unknown, although the disorder is thought to be driven by a complex cascade of proinflammatory cytokines and anti-inflammatory mediators, which may contribute to the systemic comorbidities, including metabolic syndrome, type 2 diabetes mellitus, atherosclerosis, spondyloarthropathy, and inflammatory bowel disease. (clinicalpainadvisor.com)
  • Cheung T, de Zoeten EF, Hoffenberg EJ, Liu E, Pan Z, Walker T, Stahl M. Characteristics of Children with Inflammatory Bowel Disease and Coexisting Celiac Disease Seropositivity. (cuanschutz.edu)
Endometriosis12
  • OBJECTIVE: To evaluate the efficacy of oral administration of a novel composition composed of Quercetin, Curcumin, Acetylcysteine in reducing pain in women affected by endometriosis, through the reduction of the inflammatory-hyperproliferative component of the ectopic endometrial tissue. (endometriosistreatmentreport.com)
  • First-line medical management of endometriosis-related pain includes combined hormonal contraceptives or progestin-only hormone treatment. (bcmj.org)
  • Tentative evidence suggests that the use of combined oral contraceptives reduces the risk of endometriosis. (wikipedia.org)
  • Furthermore, endometriosis costs the US economy over $2,000 more than the average worker in annual absence and short-term disability costs.5 Current treatment options remain limited to painkillers, laparoscopic removal of lesions, and hormonal therapies. (kxadvisors.com)
  • Just like normal endometrial tissue, endometriosis lesions can grow and bleed during menstruation in response to hormonal changes, causing pain and inflammation. (myendometriosisteam.com)
  • Because endometriosis lesions respond to hormonal changes during the menstrual cycle, symptoms are often cyclical. (myendometriosisteam.com)
  • Our research in the Oxford Endometriosis CaRe Centre seeks to identify what causes this disease to help improve our understanding of its different forms and to help inform novel drug and non-invasive biomarker discovery programmes. (ox.ac.uk)
  • These samples will be used in state-of-the-art biomedical assays to improve our understanding of the underlying biology of these symptoms in women with endometriosis and/or fibroids, which will lead to a better understanding of the conditions, stratification of patient groups and tailored therapies, and the development of novel drug targets and biomarkers for diagnosis and treatment. (ox.ac.uk)
  • Biomarker and drug target discovery, and the translation of genetic results into clinically useful outcomes, requires the collection of biological samples along with detailed symptomatic, clinical, and personal information from women with and without endometriosis. (ox.ac.uk)
  • The samples and data collected as part of ENDOX are used for a number of studies aimed at finding - and translating our genetic findings into - biomarkers, improve our understanding of underlying disease mechanisms and develop novel treatments for endometriosis and its associated symptoms. (ox.ac.uk)
  • This shows that endometriosis is also an inflammatory disease and needs to be treated as such (11). (endometriosissouthcoast.com)
  • The Oral contraceptives reduce the rate of postoperative endometrioma recurrence and should be considered an essential part of long-term therapeutic strategies.New agents promise a distinct perspective in endometriosis treatment. (endometriosi.it)
Progesterone2
  • Additional factors that contribute to hormonal acne formation vary, and include other hormones, such as progesterone, estrogen and cortisol. (dermcollective.com)
  • We performed a cost-minimization analysis to compare the cost of biomarker analysis for estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 status with immunohistochemistry versus STRAT4. (bvsalud.org)
Irritable bowel sy1
  • Other causes of similar symptoms include pelvic inflammatory disease, irritable bowel syndrome, interstitial cystitis, and fibromyalgia. (wikipedia.org)
Therapies1
  • Treatments include over the counter and prescription-strength topicals, oral medications and hormonal therapies. (dermcollective.com)
Lesions1
  • The simultaneous presence of multiple types of lesions - including inflammatory nodules, abscesses, inflamed and draining sinus tracts or fistulae, and rope-like scarring - can challenge accurate diagnostic evaluation. (clinicalpainadvisor.com)
Contraception5
  • Where possible, I encourage both women and men to explore and understand all the available non-hormonal contraception options, to help you to make the best choices for you, your partner and your body. (drjess.co.uk)
  • There are several good non-hormonal methods of contraception that do not interfere with our hormonal balance. (drjess.co.uk)
  • Many of my patients have found the copper (non-hormonal) coil is an easy and very effective form of long-term contraception with few side effects, as are condoms, which are very effective when used correctly. (drjess.co.uk)
  • Oral contraception may be taken in one of several ways. (drjess.co.uk)
  • The female subject's chosen form of contraception must be effective by the time the female subject starts the study (for example, hormonal contraception should be initiated at least 28 days before Day 1). (who.int)
Inflammation2
  • LACTIN-V treatment was associated with significantly lower concentrations of the proinflammatory cytokine IL-1a ( P =0.042), a marker of inflammation, and soluble E-cadherin ( P =0.035), a biomarker of epithelial barrier disruption. (naturalmedicinejournal.com)
  • This then disrupts the bi-directional communication between stem-cell signalling pathways that are affected by local inflammation which forms an inflammation-hormonal loop that is dysregulated (10). (endometriosissouthcoast.com)
Hormones2
  • Alteration in female sex hormones: their effect on oral tissues and dental treatment. (ijcrr.com)
  • 6. Zachariasen RD. The effect of elevated ovarian hormones on periodontal health: oral contraceptives and pregnancy. (ijcrr.com)
Estrogen1
  • Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. (mycanceriq.ca)
Menopause1
Symptoms1
  • Treatments target symptoms and include hormonal suppression, surgery or a combination of both approaches, as well as multidisciplinary care to address persistent pain arising from central sensitization and nociplastic pain processes, if required. (cmaj.ca)
Chronic4
  • Inflammatory states are associated with anemia of chronic disease and acute infection. (bvsalud.org)
  • Boil-like swellings are the hallmark of hidradenitis suppurativa (HS), a chronic, recurrent inflammatory skin disease of the hair follicle. (clinicalpainadvisor.com)
  • Validation of biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) across data sets has proven disappointing. (biomedcentral.com)
  • Background: Although there is substantial interest in the use of newer biomarkers to identify patients with chronic heart failure (CHF), recently few investigations have evaluated the incremental usefulness of multiple conventional biomarkers. (her2signaling.com)
Breast Cancer5
  • Collaborative Group on Hormonal Factors in Breast Cancer. (mycanceriq.ca)
  • Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. (mycanceriq.ca)
  • Objective To compare the financial and time cost of breast cancer biomarker analysis by immunohistochemistry with that by the Xpert® STRAT4 assay. (bvsalud.org)
  • Findings We estimated that breast cancer diagnosis in Rwanda costs 138.29 United States dollars (US$) per patient when conducting biomarker analysis by immunohistochemistry. (bvsalud.org)
  • Conclusion Breast cancer biomarker analysis with STRAT4 has the potential to reduce the required human and capital resources in subSaharan African laboratories, leading to improved treatment selection and better clinical outcomes. (bvsalud.org)
Efficacy2
  • The objective of this randomized, controlled trial was to examine the bioavailability, efficacy, and safety of oral ferrous bisglycinate plus folinic acid supplementation in pregnant women with iron deficiency. (bvsalud.org)
  • To collect specimens in order to evaluate biomarkers of therapeutic efficacy. (clinicaltrialsgps.com)
Disease3
  • In particular, we highlight how understanding and defining microbial community structures in different disease and physiological states have lead to the discovery of biomarkers and, more importantly, the development and implementation of microbial intervention strategies (probiotics) into modern day medicine. (frontiersin.org)
  • This approach is not taking the inflammatory side of Endo into account and patients with the disease are not being treated efficiently or effectively (6). (endometriosissouthcoast.com)
  • Female sex hormonal factors in periodontal disease. (ijcrr.com)
Factors1
  • Factors associated with a decreased risk of ovarian cancer include multiparity, use of oral contraceptives, multiple pregnancies, breastfeeding, tubal ligation, and salpingectomy. (uofmhealth.org)
GnRH1
  • The current standard of care is to treat Endo with combined oral contraceptives, progestins, or short-term treatment with gonadotropin-releasing hormone (GnRH) agonists. (endometriosissouthcoast.com)
Treatments2
  • This may include pain medication, hormonal treatments or surgery. (wikipedia.org)
  • There are a variety of treatments available to treat hormonal acne. (dermcollective.com)
Therapeutic1
Yields1
  • Protruding polypoid masses which are inflammatory in origin, soft, yields to palpation, and have a smooth, glistening surface with underlying cystically dilated spaces filled with mucinous secretion. (brainscape.com)
Include1
  • Combined hormonal contraceptives (CHCs) include low-dose (containing ≤35 μ g ethinyl estradiol) combined oral contraceptives (COCs), the combined hormonal patch, and the combined vaginal ring ( Box D1 ) ( Table D1 ). (cdc.gov)
Acne6
  • Hormonal acne is triggered by hormonal fluctuations and is characterized by clogged and inflamed pores. (dermcollective.com)
  • While anyone can develop hormonal acne, it is more prevalent among women than men across all age groups. (dermcollective.com)
  • Hormonal acne develops when pores become plugged by debris such as dead skin cells, dirt and excess sebum, the oily substance that protects the skin. (dermcollective.com)
  • What Is Hormonal Acne? (dermcollective.com)
  • Hormonal acne is simply acne that develops due to hormone fluctuations, and is characterized by clogged and inflamed hair follicles. (dermcollective.com)
  • Is there a cure for hormonal acne? (dermcollective.com)
Diagnostic2
  • At a realistic immunohistochemistry antibody utilization efficiency of 70%, biomarker analysis comprises 48.7% (US$ 67.33) of diagnostic costs and takes 33 min. (bvsalud.org)
  • les cliniciens exerçant en milieu peu équipé peuvent donc sans équivoque suivre les recommandations sur la prise en charge des tumeurs classées BIRADS2 et BIRADS3 à l'échographie, bien que sa performance en ce qui concerne le diagnostic différentiel de ces tumeurs soit moindre. (bvsalud.org)
Clinical2
  • Clinical oral investigations. (elsevierpure.com)
  • Results of trials with new oral anticoagulant drugs and vitamin K antagonists (VKA) might not be directly applicable to Dutch clinical practice due to the high level of control of anticoagulation in the Netherlands. (her2signaling.com)
Prevention1
  • Conclusion: Most pregnant women need more information about oral health, and prevention of gingival and periodontal diseases as they are more concern about general health and less aware and concern about dental health. (ijcrr.com)
Combination1
  • Combination of several biomarkers simultaneously could enhance risk stratification in CHF. (her2signaling.com)
Minus1
  • Energy availability is defined as energy obtained through oral nutrition minus energy expended during exercise. (medscape.com)
Substantially1
  • Baseline participant characteristics and sexual behaviors, including recent sex and hormonal-contraceptive use and ethnicity, did not substantially differ between groups. (naturalmedicinejournal.com)
Pain1
  • The recommended pain medication is usually a non-steroidal anti-inflammatory drug (NSAID), such as naproxen. (wikipedia.org)
Pregnancy2
  • Materials and Methods: Awareness of the relationship between oral health and pregnancy, demographics, oral health knowledge, oral hygiene, and dental visits during pregnancy and their willingness for treatment to be surveyed by self administered questionnaire from 100 pregnant females. (ijcrr.com)
  • Knowledge and awareness about use of interdental aids, extra care during pregnancy and about premature labour and low birth babies are correlated with periodontal oral health. (ijcrr.com)
Risk1
  • 4 = A condition that represents an unacceptable health risk if the contraceptive method is used. (cdc.gov)
Anticoagulants1
  • Control of anticoagulation, expressed as a percentage of person-time spent in range, in this Dutch dataset was similar to recent trials with new oral anticoagulants, although it should be noted that the Dutch INR target is higher than the target in these A-1155463 purchase trials. (her2signaling.com)
Practice3
  • The relationship between Knowledge, Attitude and Practice of Pregnant Women about Oral and Dental Care. (ijcrr.com)
  • U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. (cdc.gov)
  • Selected practice recommendations for contraceptive use. (cdc.gov)
Tissue1
METHODS2
  • FCBP about the different options of contraceptive methods or abstinence at Day 1, as appropriate. (who.int)
  • The subject will be re-educated every time her contraceptive measures/methods or ability to become pregnant changes. (who.int)
Illness1
  • These preliminary results suggest that IL-1α, 6 and 8 adjusted for illness duration may serve as robust biomarkers, independent of age, in screening for ME/CFS. (biomedcentral.com)
Women4
  • By 1981, 11% of married women in Costa Rica ages 20-49 years had used depot-medroxyprogesterone acetate (DMPA) and 58% had used oral contraceptives (OCs). (ucr.ac.cr)
  • Aim and Objective: To assess and compare the level of knowledge and attitude towards periodontal oral health among pregnant women. (ijcrr.com)
  • 1. Boggess KA, Urlaub DM, Moos MK, Polinkovsky M, El-Khorazaty J, Lorenz C. Knowledge and beliefs regarding oral health among pregnant women. (ijcrr.com)
  • Periodontal status and oral hygiene practices of pregnant and non-pregnant women. (ijcrr.com)
Study1
  • A Prospective, Randomized, Interventional Study of Oral Iron Supplementation Comparing Daily Dose with Alternate Day Regimen Using Hepcidin as a Biomarker in Iron Deficiency Anemia. (mcmaster.ca)
Group1
  • The snake venom myotoxin (MT)-III is a group IIA secreted phospholipase A2 (sPLA2) with pro-inflammatory activities. (ucr.ac.cr)
Time1
  • Audit on Patient's Attendance Pattern, Reasons for Failed Appointments and Waiting Time at Oral Health Department. (ijcrr.com)
Method1
  • 1 = A condition for which there is no restriction for the use of the contraceptive method.2 = A condition for which the advantages of using the method generally outweigh the theoretical or proven risks. (cdc.gov)
Medical1
  • U.S. medical eligibility criteria for contraceptive use, 2016. (cdc.gov)